Palisade Bio Selected for Poster Presentation at the 2024 Crohn’s & Colitis Congress
09. Januar 2024 08:00 ET
|
Palisade Bio, Inc.
Carlsbad, CA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company focused on developing novel therapeutics for serious...